Generic medicine
Potassium iodide
Potassium iodide
Data statusRegistration & price fields require source verification.
16brands/products
10companies
16with current prices
Pakistan brand index
16 resultsAvailable brands
| Brand | Manufacturer | Strength | Form | Pack | Reg. no. | Official price |
|---|---|---|---|---|---|---|
| Acti KI | Martin Dow Limited | 130 mg | Tablet | 2*10's | 107872 | PKR 53.062026-07-22 |
| Cu-Iodide | Cunningham Pharmaceuticals (Pvt.) Ltd. | 65 mg | Tablet | 20's | 111866 | PKR 36.302024-07-01 |
| Cu-Iodide | Cunningham Pharmaceuticals (Pvt.) Ltd. | 130 mg | Tablet | 20's | 111865 | PKR 50.092024-07-01 |
| Glitz Iodide | Glitz Pharma | 65 mg | Tablet | 20's | 111876 | PKR 36.902025-09-04 |
| Idokal | Pharmasol (Pvt) Ltd. | 130 mg | Tablet | 20's | 104666 | PKR 77.022026-07-24 |
| IOCAB | CCL Pharmaceuticals (Pvt.) Ltd. | 130 mg | Tablet | 20's | 111871 | PKR 75.422026-07-23 |
| IOCAB | CCL Pharmaceuticals (Pvt.) Ltd. | 65 mg | Tablet | 20's | 111872 | PKR 40.602026-07-23 |
| Iogen | Genetics Pharmaceuticals Pvt. Ltd | 130 mg | Tablet | 20's | 111869 | PKR 54.512026-07-27 |
| Iogen | Genetics Pharmaceuticals Pvt. Ltd | 65 mg | Tablet | 20's | 111870 | PKR 39.502026-07-27 |
| Iokrin | High-Q Pharmaceuticals | 65 mg | Tablet | 2 x 10's | 115976 | PKR 41.312025-08-18 |
| Iokrin | High-Q Pharmaceuticals | 130 mg | Tablet | 2 x 10's | 115975 | PKR 73.972025-08-18 |
| Ioptas | Nabiqasim Industries (Pvt) Ltd., | 130 mg | Tablet | 20’s | 108485 | PKR 55.002026-07-23 |
| Ioptas | Nabiqasim Industries (Pvt) Ltd., | 65 mg | Tablet | 20's | 110238 | PKR 44.222026-07-23 |
| Sephide | Seraph Pharmaceutical | 130 mg | Tablet | 20's | 104667 | PKR 47.832024-07-01 |
| Winpodide | Winthrox Laboratories Pvt. Ltd | 130 mg | Tablet | 2x10's | 115974 | PKR 36.592024-07-01 |
| Winpodide | Winthrox Laboratories Pvt. Ltd | 65 mg | Tablet | 2x10's | 115973 | PKR 30.502024-07-01 |
Independent editorial layer
Medicine information
Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.